MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-25-0320

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2025

Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET-Targeted Prostate Biopsy for Prostate Cancer Diagnosis.

Jiao Jianhua, Ma Shuaijun, Wu Peng, Song Xiyu, Cui Hongyong, Zhang Jingliang, Shang Lei, Zhang Wuhe, Sun Yi, Gao Jixue, Zhao Weihong, Zheng Wei, Jing Yuming, Yang Xiaojian, Zhang Jing, Wang Wenwen, Zhang Qiang, Xing Nianzeng, Wen Weihong, Shi Yongquan, Kang Fei, Qin Weijun

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

PURPOSE: Transrectal ultrasound-guided prostate biopsy (TRUS-GB) is associated with the underdiagnosis of prostate cancer, and prostate-specific membrane antigen (PSMA)-PET-targeted prostate biopsy (PSMA-TB) may reduce the misclassification of prostate cancer. The primary outcome of the study was the accuracy of the two methods in identifying clinically significant prostate cancer (csPCa). The secondary outcomes included accuracy in identifying clinically insignificant prostate cancer (GG1) and GG3 or greater tumors, cancer detection stratified by the previous biopsy status, and the detection rate of csPCa using the combination of PSMA-TB and TRUS-GB.

PATIENTS AND

METHODS

In this multicenter, two-arm, randomized study, biopsy-naïve patients suspected of having prostate cancer and advised to undergo prostate biopsy were randomly assigned to the PSMA-TB + TRUS-GB (combined) and TRUS-GB (control) groups.

RESULTS

A total of 815 men were assessed for eligibility, and 727 men were randomly assigned to the PSMA-TB + TRUS-GB group or the TRUS-GB group. The detection rate of csPCa in the group subjected to the combination of PSMA-TB and TRUS-GB was significantly greater than that in the conventional TRUS-GB group (67.0% vs. 60.1%; P = 0.042). In the PSMA-TB + TRUS-GB group, the rate of csPCa detection by PSMA-TB was significantly greater than that by TRUS-GB (63.5% vs. 57.7%; P < 0.001), whereas the combined strategies achieved the highest detection rate (67.0% vs. 63.5%, P < 0.001; 67.0% vs. 57.7%, P < 0.001).

CONCLUSIONS

The diagnostic efficacy of TRUS-GB with PSMA-TB was significantly greater than that of TRUS-GB alone. If available, PSMA-TB should be performed alongside TRUS-GB in a combined manner rather than each method alone for the most accurate pathologic results.

Для цитирования: Jiao Jianhua, Ma Shuaijun, Wu Peng, Song Xiyu, Cui Hongyong, Zhang Jingliang, Shang Lei, Zhang Wuhe, Sun Yi, Gao Jixue, Zhao Weihong, Zheng Wei, Jing Yuming, Yang Xiaojian, Zhang Jing, Wang Wenwen, Zhang Qiang, Xing Nianzeng, Wen Weihong, Shi Yongquan, Kang Fei, Qin Weijun. Transrectal Ultrasound-Guided Prostate Biopsy with and without PSMA-PET-Targeted Prostate Biopsy for Prostate Cancer Diagnosis.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025. DOI: 10.1158/1078-0432.ccr-25-0320.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.